The neurodegenerative disease gets less funder attention than other more common conditions, which is why a set of new $1 million research grants from the Hereditary Disease Foundation could really move the needle.
Read MoreThe late Microsoft co-founder’s Paul G. Allen Frontiers Group has launched its newest Discovery Center. Its goal: exploring how the human nervous system and immune system interact to shape health and disease.
Read MoreSpun out of the Wellcome Trust, the U.S.-based Burroughs Wellcome Fund continues to sharpen its focus around diversity and equity in research, supporting early-career scientists, and more.
Read MoreBhargava, a longtime insider and former grantee of the JPB Foundation, will take over from founding donor and president Barbara Picower in February 2024. We connected with him to learn more about the transition.
Read MoreThe Engelstad Foundation supported Touro University Nevada's lone biomedical lab when few other funders would. A recent discovery there could lead to new treatments for HIV, and even cancer, Alzheimer’s and more.
Read MorePhilanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.
Read MoreThe former junk bond king has been a case study in restoring one’s reputation through impactful and committed philanthropy. But don’t expect many other donors in need of reputational rehabilitation to follow in his footsteps.
Read MoreTo build up collaborative research infrastructure, a landmark $100 million gift from businessman Gene Lay will launch a new institute spanning Brigham and Women's Hospital, Mass General and Harvard Medical School.
Read MoreThe Larry L. Hillblom Foundation funds research to cure diabetes and the degenerative diseases of aging. It was founded after the death of its eponymous original donor, about whom disturbing revelations emerged.
Read MoreSerial entrepreneur Anthony Wood helped usher in the current dominance of streaming TV. Now, he’s also ramping up his philanthropy with a DAF-centric approach and interests across a range of causes.
Read MoreThe Gates Foundation, Novo Nordisk Foundation and Open Philanthropy are collaborating under a partnership called Pandemic Antiviral Discovery, funding research to develop treatments that may be needed for future pandemics.
Read MorePaul and Diane Manning, longtime supporters of diabetes research at the University of Virginia, recently committed $100 million to build an advanced biotech research institute there. Here’s a rundown on the gift and the donors.
Read MoreThe Chicago-based Muscular Dystrophy Association is a leading funder in the field of neuromuscular diseases. We check in with Chief Research Officer Dr. Sharon Hesterlee to discuss current challenges and priorities.
Read MoreThe FDA recently approved a new drug to treat ALS. Here’s how the ALS Association, equipped with funding from 2014’s viral Ice Bucket Challenge, contributed to that outcome — and what it’s looking to do next.
Read MoreOnce viewed as the “graveyard of neuroscience,” the field of spinal cord injury has made headway thanks to the Christopher & Dana Reeve Foundation. We check in with two leaders to discuss challenges and opportunities.
Read MoreThe $1.5 billion Starr Foundation likes to give out big-ticket grants to create and support new medical research centers. Its latest establishes a new basic research program at Memorial Sloan Kettering Cancer Center.
Read MorePhilanthropy in the United States has shown a particularly weak response to one disease that disproportionately affects Black people. We look at the state of philanthropy around sickle cell disease, and what needs to improve.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
